Combination of TACE and SBRT for Unresectable Single Large HCC

Combination of TACE and SBRT for Unresectable Single Large HCC

Mount Sinai Health System

8 months
39 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Michael Buckstein, MD of Mount Sinai explains the Phase II trial using combination of TACE and SBRT for unresectable single large HCC.

________

Preliminary results from this Phase II trial show very promising response rates when combining TACE+SBRT in large, unresectable HCC with excellent OS, PFS, and CSS.  These preliminary data are currently being confirmed in an expanded cohort.

Up Next Autoplay